CD44 and metabolic dysfunction-associated steatohepatitis: In vivo studies in experimental models of non-alcoholic steatohepatitis assessing CD44 deficiency suggest that HA molecules exert modulatory actions on hepatic macrophages, including resident KCs and infiltrating monocyte-derived macrophages (Figure 2).